책소개
This practical guide for advanced students and decision-makers in the pharma and biotech industry presents key success factors in R&D along with value creators in pharmaceutical innovation. A team of editors and authors with extensive experience in academia and industry and at some of the most prestigious business schools in Europe discusses in detail the innovation process in pharma as well as common and new research and innovation strategies. In doing so, they cover collaboration and partnerships, open innovation, biopharmaceuticals, translational medicine, good manufacturing practice, regulatory affairs, and portfolio management. Each chapter covers controversial aspects of recent developments in the pharmaceutical industry, with the aim of stimulating productive debates on the most effective and efficient innovation processes. A must-have for young professionals and MBA students preparing to enter R&D in pharma or biotech as well as for students on a combined BA/biomedical and natural sciences program.
[인터넷 교보문고 제공]
저자소개
저자 : Alexander Schuhmacher
ALEXANDER SCHUHMACHER is a professor for R&D management, Vice Dean of the Faculty of Applied Chemistry and Senator at Reutlingen University. And he is Director for R&D performance metrics and business model innovation at Bioscience Valuation. Before joining the academic world, he worked 14 years in the pharmaceutical industry in various functions in R&D, such as in R&D portfolio management and strategic planning. He studied biology at the University of Constance (Germany), Pharmaceutical Medicine at Witten-Herdecke University (Germany) and he is also a graduate of the Executive MBA program at the University of St. Gallen (Switzerland). MARKUS HINDER studied medicine at the Universities of Heidelberg, Paris and Z rich and obtained his doctoral degree in pharmacology and toxicology from Heidelberg University. He is board certified in clinical pharmacology, pharmaceutical medicine, emergency medicine and sports medicine. He joined the pharmaceutical industry more than 18 years ago and gained extensive experience in his positions in pharmacology, clinical pharmacology, translational medicine, late-stage clinical development, medical affairs and global project leadership functions. In addition to working in the pharmaceutical industry Markus is a professor for pharmaceutical development and regulations in the International MSc course on Pharmacoeconomics and Health Economics at Cardiff University/ Hochschule Fresenius. OLIVER GASSMANN is a Professor for technology and innovation management at St. Gallen University, where he chairs the Institute of Technology Management. His teaching activities include several executive MBA programs. He has written or edited 18 books and published more than 300 journal articles on technology and innovation management. Until 2002 he headed the R&D department of Schindler. The main focus of his research lies in open innovation and global innovation processes. He is the 1998 recipient of the RADMA Prize and in 2009 was ele
목차
Introduction to the Book Global Epidemiological DevelopmentsThe Value of Pharmaceutical Innovation: Concepts and Assessment A Review of the Pharmaceutical R&D Efficiency: Costs, Timelines and ProbabilitiesFinancing Pharmaceutical Innovation Challenges And Options For Drug Discovery Translational Medicine - Enabling the Proof of Concepts Preclinical Safety and Risk AssessmentDeveloping Commercial Solutions for Therapeutic Proteins The Evolution of Clinical Development: From Technical Success to Clinical Value Creation Translational Development 40 years of Innovation in Biopharmaceuticals - Will the Next 40 Years be as Revolutionary? Vaccines - Where Inertia, Innovation and Revolution Create Value, Simultaneously and Quietly The Patient Centric Pharma Company: Evolution, Reboot or Revolution? The Pharmaceutical Industry is Opening its R&D BoundariesOut-licensing in Pharmaceutical Research and Development Trends and Innovations in Pharmaceutical R&D Outsourcing New Innovation Models in Pharmaceutical R&D The Influence of Leadership Paradigms and Styles on Pharmaceutical Innovation The Role of Modern Portfolio Management in Pharma Innovation Patent Management throughout the Innovation Life Cycle The Pharmaceutical Industry in Search of the Next Wave of Commercially Relevant Innovation
네티즌 리뷰
등록된 리뷰가 없습니다. 이 책의 리뷰는 블로그에서 작성하실 수 있습니다.
'(NAMGUNGEUN)' 카테고리의 다른 글
| Innovation in the pharmaceutical industry Takuji Hara (0) | 2017.12.16 |
|---|---|
| Pharmaceutical Industry (0) | 2017.12.16 |
| The MBA Career Bible 2007 (Paperback) (0) | 2017.12.16 |
| MBA Pharmaceutical Industry (0) | 2017.12.16 |
| 전기화학 계면과 전극과정의 과학 기술 (0) | 2017.12.16 |